Cirrus Therapeutics: Funding, Investors & Team (Oct 2026)
Cirrus Therapeutics is a Biotechnology Research firm diganosing and treating eye diseases affecting ocular immune system.
Cirrus Therapeutics has raised $3.7M across 1 funding round on record, the most recent a Seed of $3.7M announced in Aug 2026.
That round is below the $7.6M median round size for United States companies tracked on FundedIQ over the last two years.
Cirrus Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Cirrus Therapeutics Funding Rounds
Cirrus Therapeutics Investors
Cirrus Therapeutics Founders and Leadership Team
Contact details for the Cirrus Therapeutics team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Cirrus Therapeutics Funding in Context
Cirrus Therapeutics' latest round of $3.7M is below the median round in United States. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Cirrus Therapeutics in Biotechnology and Cambridge
Companies Similar to Cirrus Therapeutics
Rheos Medical develops innovative devices to enhance pharmaceutical delivery, patient safety, and acute care.
Lionheart Longevity provides physician-led, personalized regenerative medicine, advanced diagnostics, and…
Onyx is a research collective building a virtual immune system from longitudinal human immune data.
Hone creates AI agents that can help run a business, joining a crowded field of services using the technology…
Sonilo provides an AI video-to-music platform that generates synchronized, commercially usable soundtracks…
PlotPicks is an interactive entertainment platform that combines television viewing with prediction-based…
Negosh operates a data-driven platform and marketplace that connects brand owners with manufacturers and…
Insuraviews provides software for analyzing insurance rate filings with search, analytics, and competitive…
Thrixel is an AI-powered 3D model generation platform designed to integrate directly with coding agents, AI…
Vye Health is an AI-native healthcare company that provides tools for medical providers to launch and run…
Park Golf Pitch & Putt is a sports company that focuses on outdoor entertainment with focus on pitch-putt…
Phinge® Creating Netverse®, Patented App-less, Integrated Technologies & Verifed Platform & AI With…
Cirrus Therapeutics Funding FAQs
What does Cirrus Therapeutics do?
Cirrus Therapeutics is a Biotechnology Research firm diganosing and treating eye diseases affecting ocular immune system.
How much funding has Cirrus Therapeutics raised?
Cirrus Therapeutics has raised $3.7M across 1 round on record. The most recent is a Seed of $3.7M announced in Aug 2026.
When did Cirrus Therapeutics last raise funding?
Cirrus Therapeutics' most recent funding round on record is a Seed of $3.7M, announced in Aug 2026.
Who has invested in Cirrus Therapeutics?
Investors on record for Cirrus Therapeutics include Polaris Partners, ZAKA VC, ClavystBio, Seeds Capital, Cedars-Sinai Health Ventures.
Who founded Cirrus Therapeutics?
FundedIQ lists Ying Chan (Co-Founder and CEO) at Cirrus Therapeutics.
Where is Cirrus Therapeutics headquartered?
Cirrus Therapeutics is based in Cambridge, United States.
How many employees does Cirrus Therapeutics have?
Cirrus Therapeutics is in the 1-10 employee band.
When was Cirrus Therapeutics founded?
Cirrus Therapeutics was founded in 2022.
About FundedIQ's Cirrus Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Cirrus Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.